Literature DB >> 24513079

The interplay between autophagy and apoptosis in the diabetic heart.

Changhan Ouyang1, Jieyun You1, Zhonglin Xie2.   

Abstract

Diabetic cardiomyopathy is characterized by ventricular dysfunction that occurs in diabetic patients independent of coronary artery disease, hypertension, and any other cardiovascular diseases. Diabetic cardiomyopathy has become a major cause of diabetes-related mortality. Thus, an urgent need exists to clarify the mechanism of pathogenesis. Emerging evidence demonstrates that diabetes induces cardiomyocyte apoptosis and suppresses cardiac autophagy, indicating that the interplay between the autophagy and apoptotic cell death pathways is important in the pathogenesis of diabetic cardiomyopathy. This review highlights recent advances in the crosstalk between autophagy and apoptosis and its importance in the development of diabetic cardiomyopathy. This article is part of a Special Issue entitled "Protein Quality Control, the Ubiquitin Proteasome System, and Autophagy".
© 2013.

Entities:  

Keywords:  AMPK; Apoptosis; Autophagy; Diabetic cardiomyopathy

Mesh:

Year:  2013        PMID: 24513079     DOI: 10.1016/j.yjmcc.2013.10.014

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  54 in total

1.  CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes.

Authors:  Lei Qi; Huimei Zang; Weiwei Wu; Prakash Nagarkatti; Mitzi Nagarkatti; Qinghang Liu; Jeffrey Robbins; Xuejun Wang; Taixing Cui
Journal:  J Mol Cell Cardiol       Date:  2020-06-14       Impact factor: 5.000

Review 2.  Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus.

Authors:  Reza Badalzadeh; Behnaz Mokhtari; Raana Yavari
Journal:  J Physiol Sci       Date:  2015-03-01       Impact factor: 2.781

3.  Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy.

Authors:  Ning Zhang; Zheng Yang; Shi-Zhao Xiang; Ya-Ge Jin; Wen-Ying Wei; Zhou-Yan Bian; Wei Deng; Qi-Zhu Tang
Journal:  Mol Cell Biochem       Date:  2016-05-10       Impact factor: 3.396

4.  Atorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress.

Authors:  Ahmed A M Abdel-Hamid; Alaa El-Din L Firgany
Journal:  J Mol Histol       Date:  2015-06-04       Impact factor: 2.611

Review 5.  Autophagy: a housekeeper in cardiorenal metabolic health and disease.

Authors:  Guanghong Jia; James R Sowers
Journal:  Biochim Biophys Acta       Date:  2014-06-28

Review 6.  Molecular regulation of autophagy and its implications for metabolic diseases.

Authors:  Stefan W Ryter; Ja Kun Koo; Augustine M K Choi
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2014-07       Impact factor: 4.294

7.  Mast cell-deficiency protects mice from streptozotocin-induced diabetic cardiomyopathy.

Authors:  Aina He; Wenqian Fang; Kun Zhao; Yajun Wang; Jie Li; Chongzhe Yang; Feriel Benadjaoud; Guo-Ping Shi
Journal:  Transl Res       Date:  2019-01-19       Impact factor: 7.012

8.  Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice.

Authors:  Huimei Zang; Weiwei Wu; Lei Qi; Wenbin Tan; Prakash Nagarkatti; Mitzi Nagarkatti; Xuejun Wang; Taixing Cui
Journal:  Diabetes       Date:  2020-09-18       Impact factor: 9.461

9.  Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progression.

Authors:  James T Thackeray; Stefan Pietzsch; Britta Stapel; Melanie Ricke-Hoch; Chun-Wei Lee; Jens P Bankstahl; Michaela Scherr; Jörg Heineke; Gesine Scharf; Arash Haghikia; Frank M Bengel; Denise Hilfiker-Kleiner
Journal:  JCI Insight       Date:  2017-05-18

10.  Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency.

Authors:  Qingyun Qin; Chen Qu; Ting Niu; Huimei Zang; Lei Qi; Linmao Lyu; Xuejun Wang; Mitzi Nagarkatti; Prakash Nagarkatti; Joseph S Janicki; Xing Li Wang; Taixing Cui
Journal:  Hypertension       Date:  2015-11-16       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.